Cargando…
CD4 Response Up to 5 Years After Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in Latin America and the Caribbean
We describe CD4 counts at 6-month intervals for 5 years after combination antiretroviral therapy initiation among 12 879 antiretroviral-naive human immunodeficiency virus-infected adults from Latin America and the Caribbean. Median CD4 counts increased from 154 cells/mm(3) at baseline (interquartile...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498272/ https://www.ncbi.nlm.nih.gov/pubmed/26180829 http://dx.doi.org/10.1093/ofid/ofv079 |
_version_ | 1782380595360301056 |
---|---|
author | Luz, Paula M. Belaunzarán-Zamudio, Pablo F. Crabtree-Ramírez, Brenda Caro-Vega, Yanink Hoces, Daniel Rebeiro, Peter F. Blevins, Meridith Pape, Jean W. Cortes, Claudia P. Padgett, Denis Cahn, Pedro Veloso, Valdilea G. McGowan, Catherine C. Grinsztejn, Beatriz Shepherd, Bryan E. |
author_facet | Luz, Paula M. Belaunzarán-Zamudio, Pablo F. Crabtree-Ramírez, Brenda Caro-Vega, Yanink Hoces, Daniel Rebeiro, Peter F. Blevins, Meridith Pape, Jean W. Cortes, Claudia P. Padgett, Denis Cahn, Pedro Veloso, Valdilea G. McGowan, Catherine C. Grinsztejn, Beatriz Shepherd, Bryan E. |
author_sort | Luz, Paula M. |
collection | PubMed |
description | We describe CD4 counts at 6-month intervals for 5 years after combination antiretroviral therapy initiation among 12 879 antiretroviral-naive human immunodeficiency virus-infected adults from Latin America and the Caribbean. Median CD4 counts increased from 154 cells/mm(3) at baseline (interquartile range [IQR], 60–251) to 413 cells/mm(3) (IQR, 234–598) by year 5. |
format | Online Article Text |
id | pubmed-4498272 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-44982722015-07-15 CD4 Response Up to 5 Years After Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in Latin America and the Caribbean Luz, Paula M. Belaunzarán-Zamudio, Pablo F. Crabtree-Ramírez, Brenda Caro-Vega, Yanink Hoces, Daniel Rebeiro, Peter F. Blevins, Meridith Pape, Jean W. Cortes, Claudia P. Padgett, Denis Cahn, Pedro Veloso, Valdilea G. McGowan, Catherine C. Grinsztejn, Beatriz Shepherd, Bryan E. Open Forum Infect Dis Brief Reports We describe CD4 counts at 6-month intervals for 5 years after combination antiretroviral therapy initiation among 12 879 antiretroviral-naive human immunodeficiency virus-infected adults from Latin America and the Caribbean. Median CD4 counts increased from 154 cells/mm(3) at baseline (interquartile range [IQR], 60–251) to 413 cells/mm(3) (IQR, 234–598) by year 5. Oxford University Press 2015-06-05 /pmc/articles/PMC4498272/ /pubmed/26180829 http://dx.doi.org/10.1093/ofid/ofv079 Text en © The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com. |
spellingShingle | Brief Reports Luz, Paula M. Belaunzarán-Zamudio, Pablo F. Crabtree-Ramírez, Brenda Caro-Vega, Yanink Hoces, Daniel Rebeiro, Peter F. Blevins, Meridith Pape, Jean W. Cortes, Claudia P. Padgett, Denis Cahn, Pedro Veloso, Valdilea G. McGowan, Catherine C. Grinsztejn, Beatriz Shepherd, Bryan E. CD4 Response Up to 5 Years After Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in Latin America and the Caribbean |
title | CD4 Response Up to 5 Years After Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in Latin America and the Caribbean |
title_full | CD4 Response Up to 5 Years After Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in Latin America and the Caribbean |
title_fullStr | CD4 Response Up to 5 Years After Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in Latin America and the Caribbean |
title_full_unstemmed | CD4 Response Up to 5 Years After Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in Latin America and the Caribbean |
title_short | CD4 Response Up to 5 Years After Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in Latin America and the Caribbean |
title_sort | cd4 response up to 5 years after combination antiretroviral therapy in human immunodeficiency virus-infected patients in latin america and the caribbean |
topic | Brief Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498272/ https://www.ncbi.nlm.nih.gov/pubmed/26180829 http://dx.doi.org/10.1093/ofid/ofv079 |
work_keys_str_mv | AT luzpaulam cd4responseupto5yearsaftercombinationantiretroviraltherapyinhumanimmunodeficiencyvirusinfectedpatientsinlatinamericaandthecaribbean AT belaunzaranzamudiopablof cd4responseupto5yearsaftercombinationantiretroviraltherapyinhumanimmunodeficiencyvirusinfectedpatientsinlatinamericaandthecaribbean AT crabtreeramirezbrenda cd4responseupto5yearsaftercombinationantiretroviraltherapyinhumanimmunodeficiencyvirusinfectedpatientsinlatinamericaandthecaribbean AT carovegayanink cd4responseupto5yearsaftercombinationantiretroviraltherapyinhumanimmunodeficiencyvirusinfectedpatientsinlatinamericaandthecaribbean AT hocesdaniel cd4responseupto5yearsaftercombinationantiretroviraltherapyinhumanimmunodeficiencyvirusinfectedpatientsinlatinamericaandthecaribbean AT rebeiropeterf cd4responseupto5yearsaftercombinationantiretroviraltherapyinhumanimmunodeficiencyvirusinfectedpatientsinlatinamericaandthecaribbean AT blevinsmeridith cd4responseupto5yearsaftercombinationantiretroviraltherapyinhumanimmunodeficiencyvirusinfectedpatientsinlatinamericaandthecaribbean AT papejeanw cd4responseupto5yearsaftercombinationantiretroviraltherapyinhumanimmunodeficiencyvirusinfectedpatientsinlatinamericaandthecaribbean AT cortesclaudiap cd4responseupto5yearsaftercombinationantiretroviraltherapyinhumanimmunodeficiencyvirusinfectedpatientsinlatinamericaandthecaribbean AT padgettdenis cd4responseupto5yearsaftercombinationantiretroviraltherapyinhumanimmunodeficiencyvirusinfectedpatientsinlatinamericaandthecaribbean AT cahnpedro cd4responseupto5yearsaftercombinationantiretroviraltherapyinhumanimmunodeficiencyvirusinfectedpatientsinlatinamericaandthecaribbean AT velosovaldileag cd4responseupto5yearsaftercombinationantiretroviraltherapyinhumanimmunodeficiencyvirusinfectedpatientsinlatinamericaandthecaribbean AT mcgowancatherinec cd4responseupto5yearsaftercombinationantiretroviraltherapyinhumanimmunodeficiencyvirusinfectedpatientsinlatinamericaandthecaribbean AT grinsztejnbeatriz cd4responseupto5yearsaftercombinationantiretroviraltherapyinhumanimmunodeficiencyvirusinfectedpatientsinlatinamericaandthecaribbean AT shepherdbryane cd4responseupto5yearsaftercombinationantiretroviraltherapyinhumanimmunodeficiencyvirusinfectedpatientsinlatinamericaandthecaribbean |